We are live on ! Find out more
RP

Riverwater Partners Portfolio holdings

AUM $300M
1-Year Est. Return 26.4%
This Fund
S&P 500
This Quarter Est. Return
+2.16%
1 Year Est. Return
+26.4%
3 Year Est. Return
+85.45%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$206M
AUM Growth
+$4.07M
Cap. Flow
+$3.06M
Cap. Flow %
1.49%
Top 10 Hldgs %
26.23%
Holding
235
New
29
Increased
97
Reduced
65
Closed
23

Top Buys

Rank Stock Value
1
EXEL icon
Exelixis
EXEL
+$1.86M
2
ITGR icon
Integer Holdings
ITGR
+$1.6M
3
PCRB
Putnam ESG Core Bond ETF
PCRB
+$1.54M
4
LMNR icon
Limoneira
LMNR
+$1.49M
5
NCMI icon
National CineMedia
NCMI
+$1.39M

Top Sells

Rank Stock Value
1
ANIK icon
Anika Therapeutics
ANIK
+$2.55M
2
ICFI icon
ICF International
ICFI
+$1.79M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$1.76M
4
THG icon
Hanover Insurance
THG
+$1.64M
5
UTL icon
Unitil
UTL
+$1.49M

Sector Composition

Rank Sector Weight
1 Financials 16.75%
2 Technology 14.11%
3 Healthcare 11.23%
4 Industrials 9.56%
5 Consumer Staples 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WAL icon
26
Western Alliance Bancorporation
WAL
$8.81B
$1.91M 0.93%
22,904
+575
+3% +$50.6K
EXEL icon
27
Exelixis
EXEL
$13.9B
$1.91M 0.93%
+57,444
New +$1.86M
PLMR icon
28
Palomar
PLMR
$3.79B
$1.91M 0.93%
18,052
+20
+0.1% +$2.03K
VSTS icon
29
Vestis
VSTS
$1.97B
$1.9M 0.93%
124,819
+40,216
+48% +$605K
MSFT icon
30
Microsoft
MSFT
$2.9T
$1.82M 0.88%
4,309
+153
+4% +$65.2K
NCMI icon
31
National CineMedia
NCMI
$378M
$1.79M 0.87%
270,307
+202,164
+297% +$1.39M
SKWD icon
32
Skyward Specialty Insurance
SKWD
$2.53B
$1.77M 0.86%
35,013
+862
+3% +$41.9K
MMSI icon
33
Merit Medical Systems
MMSI
$4.82B
$1.75M 0.85%
18,068
+20
+0.1% +$1.99K
CFR icon
34
Cullen/Frost Bankers
CFR
$10.5B
$1.73M 0.84%
12,906
+4,957
+62% +$651K
SCHW
35
Charles Schwab
SCHW
$182B
$1.63M 0.79%
22,039
-1,341
-6% -$100K
ITGR icon
36
Integer Holdings
ITGR
$3.39B
$1.59M 0.77%
+11,982
New +$1.6M
DGX icon
37
Quest Diagnostics
DGX
$26B
$1.56M 0.76%
10,358
+152
+1% +$23.6K
GOLD
38
Gold.com Inc
GOLD
$1.16B
$1.53M 0.74%
55,782
+11,008
+25% +$374K
PCRB
39
DELISTED
Putnam ESG Core Bond ETF
PCRB
$1.52M 0.74%
+31,581
New +$1.54M
BRK.B icon
40
Berkshire Hathaway Class B
BRK.B
$1.1T
$1.5M 0.73%
3,311
-49
-1% -$22.6K
CIEN icon
41
Ciena
CIEN
$46.8B
$1.49M 0.73%
17,604
-246
-1% -$17.7K
DOX icon
42
Amdocs
DOX
$6.03B
$1.44M 0.7%
16,937
+8,479
+100% +$744K
ICFI icon
43
ICF International
ICFI
$1.5B
$1.41M 0.68%
11,789
-11,943
-50% -$1.79M
PJT icon
44
PJT Partners
PJT
$4.26B
$1.39M 0.68%
8,810
+10
+0.1% +$1.52K
MGNI icon
45
Magnite
MGNI
$2.83B
$1.34M 0.65%
84,169
+90
+0.1% +$1.32K
JLL icon
46
Jones Lang LaSalle
JLL
$15.8B
$1.33M 0.65%
5,246
+148
+3% +$39.4K
AVSE icon
47
Avantis Responsible Emerging Markets Equity ETF
AVSE
$202M
$1.3M 0.63%
+25,836
New +$1.38M
UNH icon
48
UnitedHealth
UNH
$382B
$1.28M 0.62%
2,531
+151
+6% +$85.8K
AZZ icon
49
AZZ Inc
AZZ
$4.24B
$1.28M 0.62%
15,595
+440
+3% +$37.3K
PGR icon
50
Progressive
PGR
$128B
$1.24M 0.6%
5,183
-875
-14% -$220K
1
2
3 4 5

Similar funds

UCB
United Community Bank Greenville, South Carolina $300M AUM 14.66% 1-Year Est. Return
SC
Sykon Capital Harrison, New York $300M AUM 16.74% 1-Year Est. Return
FPCG
Forum Private Client Group Fishers, Indiana $300M AUM 12.15% 1-Year Est. Return
CIM
Corbyn Investment Management Lutherville, Maryland $300M AUM 18.88% 1-Year Est. Return
RCA
Riverview Capital Advisers Boston, Massachusetts $300M AUM 10.98% 1-Year Est. Return
RL
Rogco LP Claremore, Oklahoma $300M AUM 16.35% 1-Year Est. Return
JGIA
Jackson Grant Investment Advisers Stamford, Connecticut $300M AUM 13.94% 1-Year Est. Return
KEM
Kimmeridge Energy Management New York $299M AUM 36.96% 1-Year Est. Return

Riverwater Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Riverwater Partners held 235 positions worth $206M, up 2% from $201M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Riverwater Partners's Q4 2024 filing shows 29 new, 97 increased, 65 reduced and 23 closed positions. Its largest new stake was Exelixis: 57,444 shares worth $1.91M. The largest sale was Anika Therapeutics, an estimated $2.55M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Riverwater Partners's largest Q4 2024 buy was Exelixis: 57,444 shares worth $1.91M.
  • Riverwater Partners added most to Limoneira in Q4 2024, an estimated $1.49M increase.
  • Riverwater Partners's biggest Q4 2024 reduction was ICF International, cutting an estimated $1.79M.
  • Riverwater Partners fully exited Anika Therapeutics in Q4 2024, selling an estimated $2.55M.
  • Riverwater Partners's ten largest holdings make up 26% of its $206M portfolio in Q4 2024.
  • Riverwater Partners opened 29 new positions and closed 23 in Q4 2024.
  • Riverwater Partners's portfolio value rose 2% quarter-over-quarter to $206M.

Based on Riverwater Partners's 13F filing for Q4 2024, filed 13 Feb 2025.